申请人:Meiji Seika Kaisha, Ltd.
公开号:EP1941873A1
公开(公告)日:2008-07-09
A new metallo-β-lactamase inhibitor which acts as a medicament for inhibiting the inactivation of β-lactam antibiotics and recovering anti-bacterial activities is disclosed. The maleic acid derivatives having the general formula (I) have metallo-β-lactamase inhibiting activities. It is possible to recover the anti-bacterial activities of β-lactam antibiotics against metallo-β-lactamase producing bacteria by combining the compound of the general formula (I) with β-lactam antibiotics.
本发明公开了一种新的金属-β-内酰胺酶抑制剂,它可作为一种抑制β-内酰胺类抗生素失活并恢复抗菌活性的药物。具有通式(I)的马来酸衍生物具有金属-β-内酰胺酶抑制活性。通过将通式(I)的化合物与β-内酰胺类抗生素结合,可以恢复β-内酰胺类抗生素对产生金属-β-内酰胺酶的细菌的抗菌活性。